Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07342946). This is a study registration, not published results. Lead sponsor: Atlas University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 32 participants (ESTIMATED). Conditions: PCOS (Polycystic Ovary Syndrome). Interventions: DIETARY_SUPPLEMENT: Synbiotic Supplement; OTHER: Placebo. Primary outcome measures: Change in body weight , From enrollment to the end of treatment at 8 weeks; Change in body mass index (BMI) , From enrollment to the end of treatment at 8 weeks; Change in body composition , From enrollment to the end of treatment at 8 weeks; Change in waist circumference , From enrollment to the end of treatment at 8 weeks; Change in hip circumference , From enrollment to the end of treatment at 8 weeks. Brief summary: This study will look at whether a reduced-calorie Mediterranean-style eating plan, together with a synbiotic supplement, can improve health measures and quality of life in women who have polycystic ovary syndrome (PCOS) and are overweight or have obesity. Participants will be assigned by chance (like flipping a coin) to receive either the synbiotic supplement or a placebo (a look-alike product with no active ingredients). All participants will follow the same reduced-calorie Mediterranean diet for 8 weeks. The study team will measure body composition and weight-related measurements, and will collect blood samples to evaluate selected laboratory markers before and after the 8-week period. Participants will also complete the PCOSQ-50 quality-of-life questionnaire before and after the intervention. The goal is to better understand the possible role of synbiotic supplementation alongside dietary treatment in PCOS.